Company / Financials
Pharma-Bio Serv, Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$9.0M
FY2025 · -5.3% YoY
Net Income
-$100.5K
FY2025 · +87.1% YoY
Profit Margin
-1.1%
FY2025 · net income / revenue
ROE
-0.8%
FY2025 · return on equity
Total Assets
$13.7M
FY2025
Total Debt
-
FY2025
Equity
$11.9M
FY2025
ROA
-0.7%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$9.0M-5.3% YoYNet Income HistoryProfit after all expenses and taxes-$100.5K+87.1% YoYGross Profit HistoryRevenue minus cost of goods sold$2.9M+15.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$6.1M-12.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$637.7K+50.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.5M-6.7% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$6.2K-72.0% YoYEPS (Basic) HistoryBasic earnings per share-EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.03-159.6% YoY